This study represents the first assessment of YY1 mRNA and protein expression levels in peripheral blood from BC patients, which have been correlated with imaging parameters from hybrid 18F-FDG-PET/MRI in order to improve the early detection of metastatic disease. This evidence concerns the gene YY1 and breast cancer.